Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France

被引:467
作者
Poirel, L
Naas, T
Nicolas, D
Collet, L
Bellais, S
Cavallo, JD
Nordmann, P
机构
[1] Hop Bicetre, Serv Bacteriol Virol, Assistance Publ HOp Paris, Fac Med Paris Sud, F-94275 Le Kremlin Bicetre, France
[2] Inst J Paoli I Calmettes, Biol Lab, F-13273 Marseille, France
[3] Hop Instruct Armees Begin, Med Biol Lab, F-94160 St Mande, France
关键词
D O I
10.1128/AAC.44.4.891-897.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pseudomonas aeruginosa COL-1 was identified in a blood culture of a 39-year-old-woman treated,vith imipenem in Marseilles, France, in 1996. This strain was resistant to beta-lactams, including ureidopenicillins, ticarcillin-clavulanic acid, cefepime, ceftazidime, imipenem, and meropenem, but remained susceptible to the monobactam aztreonam. The carbapenem-hydrolyzing beta-lactamase gene of P. aeruginosa COL I was cloned, sequenced, and expressed in Escherichia coli DH10B. The deduced 266-amino-acid protein was an Ambler class B beta-lactamase, with amino acid identities of 32% with E-II from Bacillus cereus; 31% with IMP-1 from several gram-negative rods in Japan, including P. aeruginosa; 27%,vith CcrA from Bacteroides fragilis; 24% with BlaB from Chryseobacterium meningosepticum; 24% with IND-1 from Chryseobacterium indologenes; 21% with CphA-l from Aeromonas hydrophila; and 11% with L-1 from Stenotrophomonas maltophilia. It was most closely related to VIM-I beta-lactamase recently reported from Italian P. aeruginosa clinical isolates (90% amino acid identity). Purified VIM-2 beta-lactamase had a pI of 5.6, a relative molecular mass of 29.7 kDa, and a broad substrate hydrolysis range, including penicillins, cephalosporins, cephamycins, oxacephamycins, and carbapenems, but not monobactams. As a metallo-beta-lactamase, its activity was zinc dependent and inhibited by EDTA (50% inhibitory concentration, 50 mu M). VIM-2 conferred a resistance pattern to beta-lactams in E. coli DH10B that paralleled its in vitro hydrolytic properties, except for susceptibility to ureidopenicillins, carbapenems, and cefepime. bla(VIM-2), was located on a ca. 45-kb plasmid that in addition conferred resistance to sulfamides and that was not self-transmissible either from P. aeruginosa to E. coli or from E. coli to E. coli. bla(VIM-2), was the only gene cassette located,within the variable region of a novel class I integron, In56, that was weakly related to the bla(VIM-1)-containing integron. VIM-2 is the second carbapenem-hydrolyzing metalloenzyme characterized from a P. aeruginosa isolate outside Japan.
引用
收藏
页码:891 / 897
页数:7
相关论文
共 27 条
  • [1] A NOVEL INTEGRON-LIKE ELEMENT CARRYING THE METALLO-BETA-LACTAMASE GENE BLA(IMP)
    ARAKAWA, Y
    MURAKAMI, M
    SUZUKI, K
    ITO, H
    WACHAROTAYANKUN, R
    OHSUKA, S
    KATO, N
    OHTA, M
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) : 1612 - 1615
  • [2] Molecular characterization of a carbapenem-hydrolyzing β-lactamase from Chryseobacterium (Flavobacterium) indologenes
    Bellais, S
    Léotard, S
    Poirel, L
    Naas, T
    Nordmann, P
    [J]. FEMS MICROBIOLOGY LETTERS, 1999, 171 (02) : 127 - 132
  • [3] Metallo-β-lactamases:: A class apart
    Bush, K
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 27 : S48 - S53
  • [4] EXPRESSION OF ANTIBIOTIC-RESISTANCE GENES IN THE INTEGRATED CASSETTES OF INTEGRONS
    COLLIS, CM
    HALL, RM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (01) : 155 - 162
  • [5] Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannii clinical isolates
    Da Silva, GJ
    Leitao, R
    Peixe, L
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (06) : 2109 - 2110
  • [6] AN OVERVIEW OF THE KINETIC-PARAMETERS OF CLASS-B BETA-LACTAMASES
    FELICI, A
    AMICOSANTE, G
    ORATORE, A
    STROM, R
    LEDENT, P
    JORIS, B
    FANUEL, L
    FRERE, JM
    [J]. BIOCHEMICAL JOURNAL, 1993, 291 : 151 - 155
  • [7] Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant gram-negative rods carrying the metallo-β-lactamase gene blaIMP
    Hirakata, Y
    Izumikawa, K
    Yamaguchi, T
    Takemura, H
    Tanaka, H
    Yoshida, R
    Matsuda, J
    Nakano, M
    Tomono, K
    Maesaki, S
    Kaku, M
    Yamada, Y
    Kamihira, S
    Kohno, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) : 2006 - 2011
  • [8] CLONING AND SEQUENCING OF THE METALLOTHIOPROTEIN BETA-LACTAMASE-II GENE OF BACILLUS-CEREUS 569/H IN ESCHERICHIA-COLI
    HUSSAIN, M
    CARLINO, A
    MADONNA, MJ
    LAMPEN, JO
    [J]. JOURNAL OF BACTERIOLOGY, 1985, 164 (01) : 223 - 229
  • [9] Structure of In31, a blaIMP-containing Pseudomonas aeruginosa integron phyletically related to In5, which carries an unusual array of gene cassettes
    Laraki, N
    Galleni, M
    Thamm, I
    Riccio, ML
    Amicosante, G
    Frère, JM
    Rossolini, GM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) : 890 - 901
  • [10] Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate
    Lauretti, L
    Riccio, ML
    Mazzariol, A
    Cornaglia, G
    Amicosante, G
    Fontana, R
    Rossolini, GM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) : 1584 - 1590